March 2013
In March we featured a technology from a fellow national laboratory. You will hear about a new portable point of care diagnostics platform to run multiple assays in minutes from a single drop of blood or other bodily fluids.
Porella : features, morphology, anatomy, reproduction etc.
SpinDx™ by Anup Singh, Ph.D., Sandia National Laboratories
1. SpinDx™
A new portable point of care
diagnostic platform to run multiple
assays in minutes from a single drop
of blood or other bodily fluids
Anup Singh, Ph.D.
Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for
the U.S. Department of Energy’s National Nuclear Security Administration under contract DE-AC04-94AL85000. SAND NO. 2011-XXXXP
2. SpinDx ™ Description
A lab-on-a-disk prototype platform with the potential to run up to 64
simultaneous assays in a matter of minutes using a single drop of
blood, saliva, urine, or other sample.
Key Advantages:
1) Small size and cost (< $1000 for the
reader, <$2 for disk)
2) Analytical sensitivity (>10-100-fold better
than most commercial ELISAs)
3) Multiplexing (up to 64 assays per disk)
4) Fast (sample-to-answer in <15 min )
5) No sample prep required
3. How does it work?
SpinDx is a “plug and play” device that
consists of a reader and a disk containing
the reagents for assays
User needs to add 2-20L of whole blood,
serum, or saliva to the disk, load the disk
into the reader, and hit the “start” button to
run the assay
Assay takes about 15 min and the results
are displayed on the LCD screen of the
device or on a computer connected to the
device
Disk is single use, but can run up to 64
assays simultaneously on the same sample
4. What is the underlying technology
SpinDx uses a novel sedimentation
approach to conduct bead-based sandwich
immunoassays.
Disk contains fluorescently-labeled
“detection” antibodies and beads carrying
“capture” antibodies in the sample loading
chamber. Disk also contains density
centrifugation media in the separation zone.
Sample is loaded and incubated for a few
minutes. Then disk is spun to separate the
beads from unreacted reagents and sample.
An optical detector reads the fluorescence
signal from the sedimented beads.
5. Competitive Differentiation from other
centrifugal devices
5
www.abaxis.com
www.gyros.com
Samsung, LLC
• Our method is different -- no other
platform uses bead-based assays
together with sedimentation.
• Combination of high surface area offered
by beads, integration of signal over
multiple beads, and complete removal of
sample matrix before detection provides
unsurpassed detection sensitivity.
• No sample preparation required even for
whole blood, making SpinDx easy to use
and compatible with many types of
sample matrices.
• Assays are fast and the reader is simple
and inexpensive.
6. Key Advantages: No Sample Prep
Density-based sedimentation allows analysis of complex sample matrices
(sample matrix is completely separated from beads before detection)
Compatible with clinical (whole blood, serum, saliva), environmental, and food
samples
7. Key Advantages: Multiplexing
Disk can have up to 64 channels and each channel can perform
one assay starting from a single sample. Sample is automatically
distributed among 64 channels
Single inlet port, sample routed via capillary action
Repeatable volume dispensing using channel geometry
8. Key Advantages: Size, Cost and Speed
Device dimensions = 5.2” (132mm)
cubed; disk diameter ~ 4”
Sample-to-answer time: ~15 min for
most assays; extreme sensitivity
may require additional incubation
time making the total assay time
~30 min
Estimated cost to produce SpinDx in
large quantity
Disks: Less than $2
Device: less than $1000
9. Technology Opportunity
Current Technology Readiness Level (TRL): 5-6
working prototype; have developed assays for cytokines,
cardiac markers, immune response markers and biotoxins.
Commercial readiness:
Disks are easily manufacturable from inexpensive plastic
Beads used are commercially available and conjugation
chemistry is simple
Device uses standard commercially available components
Intellectual Property:
6 U.S. patent applications pending
Currently licensed nonexclusively to two companies
10. What are we looking for?
Partners to commercialize
technology via
Licensing
Currently pursuing nonexclusive
Field of Use licensing for this
technology
CRADAS
Currently pursuing CRADA
partners to further
commercialization efforts
11. Contact Information
For information about CRADAs or licensing this technology:
Bianca Thayer, Licensing Executive
(925)-294-1214
bkthaye@sandia.gov
To view a video about SpinDx™, go to the following website:
http://www.youtube.com/watch?v=sXMCqdFj41Q&feature=youtu.be
To access publications and articles about SpinDx™, go
to this website:
https://ip.sandia.gov/technology.do/techID=82